CASES OF RELAPSED AND REFRACTORY B CELL PRECURSOR-ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY

被引：0
|
作者：
Kurita, Daisuke [1 ]
Yamanishi, Jun [1 ]
Osuna, Mitsumasa [1 ]
Ikeda, Junji [1 ]
Tsujimoto, Shinichi [1 ]
Takeuchi, Masanobu [1 ]
Tanoshima, Reo [1 ]
Shiba, Norio [1 ]
机构：
[1] Yokohama City Univ Med, Dept Pediat, Yokohama, Kanagawa, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2024年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-076
引用
收藏
页码：S104 / S104
页数：1
相关论文
共 50 条
  • [41] A retrospective comparison of allogenic and autologous chimeric antigen receptor T cell therapy targeting CD19 in patients with relapsed/refractory acute lymphoblastic leukemia
    Hu, Yongxian
    Wang, Jiasheng
    Wei, Guoqing
    Yu, Jian
    Luo, Yi
    Shi, Jimin
    Wu, Wenjun
    Zhao, Kui
    Xiao, Lei
    Zhang, Yanlei
    Wu, Zhao
    Xu, Huijun
    Chang, Alex Hongsheng
    Huang, He
    BONE MARROW TRANSPLANTATION, 2019, 54 (08) : 1208 - 1217
  • [42] OBSERVATIONAL STUDY OF CHILDREN REQUIRING CRITICAL CARE AFTER CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY FOR REFRACTORY/ RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA
    Ramanathan, G.
    Gupta, C.
    Bonney, D.
    PEDIATRIC CRITICAL CARE MEDICINE, 2022, 23 (11)
  • [43] A retrospective comparison of allogenic and autologous chimeric antigen receptor T cell therapy targeting CD19 in patients with relapsed/refractory acute lymphoblastic leukemia
    Yongxian Hu
    Jiasheng Wang
    Guoqing Wei
    Jian Yu
    Yi Luo
    Jimin Shi
    Wenjun Wu
    Kui Zhao
    Lei Xiao
    Yanlei Zhang
    Zhao Wu
    Huijun Xu
    Alex Hongsheng Chang
    He Huang
    Bone Marrow Transplantation, 2019, 54 : 1208 - 1217
  • [44] Checkpoint Inhibitors Augment CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy in Relapsed B-Cell Acute Lymphoblastic Leukemia
    Li, Amanda M.
    Hucks, George E.
    Dinofia, Amanda M.
    Seif, Alix E.
    Teachey, David T.
    Baniewicz, Diane
    Callahan, Colleen
    Fasano, Christina
    McBride, Beth
    Gonzalez, Vanessa
    Nazimuddin, Farzana
    Porter, David L.
    Lacey, Simon F.
    June, Carl H.
    Grupp, Stephan A.
    Maude, Shannon L.
    BLOOD, 2018, 132
  • [45] Infection Complications after Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin Lymphoma
    Korell, Felix
    Schubert, Maria-Luisa
    Sauer, Tim
    Schmitt, Anita
    Derigs, Patrick
    Weber, Tim Frederik
    Schnitzler, Paul
    Mueller-Tidow, Carsten
    Dreger, Peter
    Schmitt, Michael
    CANCERS, 2021, 13 (07)
  • [46] Improving and Maintaining Responses in Pediatric B-Cell Acute Lymphoblastic Leukemia Chimeric Antigen Receptor-T Cell Therapy
    Arya, Rahul
    Barrett, David M.
    Grupp, Stephan A.
    Melenhorst, Jan Joseph
    CANCER JOURNAL, 2021, 27 (02): : 151 - 158
  • [47] Chimeric Antigen Receptor T Cell Therapy for Acute Myeloid Leukemiachimeric Antigen Receptor T Cell Therapy for Acute Myeloid Leukemia
    Shrestha, Bishwas
    Vishwasrao, Paresh
    Li, Gongbo
    Ghafoor, Tayyebb
    Davila, Marco L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S96 - S97
  • [48] Treatment response, survival, safety, and predictive factors to chimeric antigen receptor T cell therapy in Chinese relapsed or refractory B cell acute lymphoblast leukemia patients
    Li, Limin
    Liu, Jie
    Xu, Mengyuan
    Yu, Hongjuan
    Lv, Chengfang
    Cao, Fenglin
    Wang, Zhenkun
    Fu, Yueyue
    Zhang, Mingwen
    Meng, Hongbin
    Zhang, Xiaoqian
    Kang, Liqing
    Zhang, Zhuo
    Li, Jinmei
    Feng, Jiawei
    Lian, Xin
    Yu, Lei
    Zhou, Jin
    CELL DEATH & DISEASE, 2020, 11 (03)
  • [49] Treatment response, survival, safety, and predictive factors to chimeric antigen receptor T cell therapy in Chinese relapsed or refractory B cell acute lymphoblast leukemia patients
    Limin Li
    Jie Liu
    Mengyuan Xu
    Hongjuan Yu
    Chengfang Lv
    Fenglin Cao
    Zhenkun Wang
    Yueyue Fu
    Mingwen Zhang
    Hongbin Meng
    Xiaoqian Zhang
    Liqing Kang
    Zhuo Zhang
    Jinmei Li
    Jiawei Feng
    Xin Lian
    Lei Yu
    Jin Zhou
    Cell Death & Disease, 11
  • [50] Chimeric antigen receptor T-cell therapy for relapsed and refractory thyroid cancer
    Ding, Jing
    Li, Deyu
    Liu, Xingchen
    Hei, Hu
    Sun, Baoxi
    Zhou, Dongmin
    Zhou, Keshu
    Song, Yongping
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2022, 11 (01)
12345